Decoding Itch in CKD: From CKD-aP Suspicion to Solution
James Burton, DM, FRCP
Leonie Kraft, MD
Lucio Manenti, MD, PhD
Emilio Sanchez, MD, PhD
Kappa-Opioid Settings: Real-World Evidence Insights
CKD-aP or Something Else? Decoding the Diagnosis
The Patient-Clinician Connection in Managing CKD-aP
Future Directions in Managing Hyperkalemia in CKD and HF
Javed Butler, MD, MPH, MBA
Implementing Potassium Binders: Practical Dosing and Long-Term Follow Up
Ellie Kelepouris, MD, FACP, FAHA
Optimizing RAASi/MRA Therapy in Patients with Heart Failure, CKD, and Hyperkalemia: A Microlearning Curriculum Approach
Javed Butler, MD
Patrick Rossignol, MD, PhD
Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
Potassium Binders: Safety Comes First!
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF
Latest Data Publication on Quantifying the Link Between TTR Response and Mortality Reduction
Daniel Judge, MD
Breaking New Ground: Acoramidis Reduces AF Events in ATTR CM Patients from ESC Heart Failure 2025
Kevin Alexander, MD
Continuity in Care: Strategies for Managing Growth Hormone Deficiency Through Life’s Stages
Aristides Maniatis, MD
Kari Hosack
Meagan Broeckert
Sam Watson
VNS: Beyond Seizure Control
Raman Sankar, MD, PhD
Scott Aaronson, MD
Differentiating Neuromodulation Therapies: VNS, DBS, ECT, TMS
QoL Matters: Brain Stem Stimulation in Patients With Unipolar Depression